Clinical Trial Update: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial comparing subcutaneous versus intravenous rituximab in combination with chemotherapy for chronic lymphocytic leukemia has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2015-12-15